Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-018478)

Filing Details

Accession Number:: 0001209191-22-018478
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-14 16:37:01
Reporting Period:: 2022-03-10

Accepted Time:: 2022-03-14 16:37:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Protara Therapeutics Inc.	TARA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192128	M Luke Beshar	C/O Protara Therapeutics, Inc. 345 Park Avenue South, 3Rd Floor New York NY 10010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-10	10,000	$4.46	178,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.